Table 2 Comparison of clinical course between early-onset idiopathic chronic pancreatitis(a) and late-onset idiopathic chronic pancreatitis(a) in different cut-offs of age at onset of idiopathic chronic pancreatitis.
From: Classification of Early-Onset and Late-Onset Idiopathic Chronic Pancreatitis Needs Reconsideration
Items | EOICP15 N = 180 | LOICP15 N = 1453 | EOICP25 N = 412 | LOICP25 N = 1221 | EOICP35 N = 685 | LOICP35 N = 948 | EOICP45 N = 1045 | LOICP45 N = 588 | EOICP55 N = 1327 | LOICP55 N = 306 | EOICP65 N = 1527 | LOICP65 N = 106 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male sex | 86 (47.8%) | 945 (65.0%)§ | 216 (52.4%) | 815 (66.7%)§ | 383 (55.9%) | 648 (68.4%)§ | 642 (61.4%) | 389 (66.2%)# | 824 (62.1%) | 207 (67.6%)# | 959 (62.8%) | 72 (67.9%)# |
Age at the onset of CP, y* | 10.401 (6.701, 13.019) | 40.441 (29.319, 52.408)§ | 16.141 (11.256, 20.544) | 44.030 (35.848, 55.123)§ | 22.022 (14.669, 28.788) | 48.827 (40.990, 57.288)§ | 28.997 (18.944, 37.559) | 55.458 (49.601, 62.158)§ | 33.619 (21.641, 43.219) | 61.918 (57.651, 68.899)§ | 37.088 (23.915, 47.943) | 70.610 (68.786, 73.358)§ |
Age at the diagnosis of CP, y* | 16.380 (12.799, 22.129) | 45.225 (35.595, 56.329)§ | 20.966 (16.362, 27.880) | 48.269 (39.482, 58.143)§ | 28.266 (19.758, 34.840) | 51.510 (44.251, 60.327)§ | 35.260 (24.311, 42.115) | 58.169 (52.373, 63.864)§ | 38.885 (27.567, 47.904) | 63.173 (59.526, 70.525)§ | 41.449 (29.770, 51.449) | 72.343 (69.559, 75.422)§ |
Initial manifestations | § | § | § | § | § | # | ||||||
Abdominal pain | 176 (97.8%) | 1170 (80.5%) | 384 (93.2%) | 962 (78.8%) | 609 (88.9%) | 737 (77.7%) | 895 (85.6%) | 451 (76.7%) | 1125 (84.8%) | 221 (72.2%) | 1261 (82.6%) | 85 (80.2%) |
Endocrine/Exocrine dysfunction | 4 (2.2%) | 174 (12.0%) | 18 (4.4%) | 160 (13.1%) | 49 (7.2%) | 129 (13.6%) | 106 (10.1%) | 72 (12.2%) | 138 (10.4%) | 40 (13.1%) | 168 (11.0%) | 10 (9.4%) |
Others | 0 (0.0%) | 109 (7.5%) | 10 (2.4%) | 99 (8.1%) | 27 (3.9%) | 82 (8.6%) | 44 (4.2%) | 65 (11.1%) | 64 (4.8%) | 45 (14.7%) | 98 (6.4%) | 11 (10.4%) |
Pancreatic stones† | 167 (92.8%) | 1025 (70.5%)§ | 374 (90.8%) | 818 (67.0%)§ | 596 (87.0%) | 596 (62.9%)§ | 858 (82.1%) | 334 (56.8%)§ | 1039 (78.3%) | 153 (50.0%)§ | 1143 (74.9%) | 49 (46.2%)§ |
Time between onset and pancreatic stone* | 7.419 (2.499, 13.756) | 2.255 (0.166,7.048)§ | 5.192 (1.419, 13.008) | 2.003 (0.134, 6.332)§ | 4.430 (1.000, 11.112) | 1.499 (0.061, 5.751)§ | 3.745 (0.832, 9.882) | 0.666 (0.000, 4.836)§ | 3.255 (0.501, 9.006) | 0.419 (0.000, 3.586)§ | 3.002 (0.337, 8.510) | 0.022 (0.000, 2.436)§ |
DM | 17 (9.4%) | 413 (28.4%)§ | 52 (12.6%) | 378 (31.0%)§ | 129 (18.8%) | 301 (31.8%)§ | 251 (24.0%) | 179 (30.4%)|| | 354 (26.7%) | 76 (24.8%)# | 405 (26.5%) | 25 (23.6%)# |
Time between onset and DM* | 21.014 (2.252, 26.141) | 1.416 (0.000, 7.170)§ | 16.011 (1.960, 23.012) | 1.086 (0.000, 5.587)§ | 9.008 (0.373, 16.597) | 0.753 (0.000, 3.822)§ | 3.323 (0.000, 10.589) | 0.334 (0.000, 2.507)§ | 2.463 (0.000, 8.691) | 0.000 (0.000, 0.979)§ | 2.003 (0.000, 7.838) | 0.000 (0.000, 0.188)§ |
Steatorrhea | 24 (13.3%) | 315 (21.7%)|| | 72 (17.5%) | 267 (21.9%)# | 151 (22.0%) | 188 (19.8%)# | 239 (22.9%) | 100 (17.0%)|| | 292 (22.0%) | 47 (15.4%)¶ | 334 (21.9%) | 5 (4.7%)§ |
Time between onset and steatorrhea* | 12.595 (4.503, 21.014) | 1.085 (0.000, 9.093)§ | 7.882 (1.416, 20.014) | 1.000 (0.000, 8.005)§ | 5.005 (0.011, 13.841) | 0.249 (0.000, 6.232)§ | 3.249 (0.000, 11.425) | 0.162 (0.000, 5.175)§ | 2.463 (0.000, 10.443) | 0.112 (0.000, 1.085)§ | 1.671 (0.000, 9.614) | 6.838 (3.921, 8.501)# |
Biliary stricture | 14 (7.8%) | 245 (16.9%)|| | 26 (6.3%) | 233 (19.1%)§ | 49 (7.2%) | 210 (22.2%)§ | 116 (11.1%) | 143 (24.3%)§ | 172 (13.0%) | 87 (28.4%)§ | 225 (14.7%) | 34 (32.1%)§ |
Time between onset and CBD stenosis* | 27.618 (12.258, 37.319) | 1.501 (0.167, 6.145)§ | 21.016 (9.340, 31.628) | 1.211 (0.167, 6.014)§ | 10.419 (4.332, 24.014) | 0.916 (0.077, 4.444)§ | 4.332 (0.918, 10.982) | 0.748 (0.077, 3.332)§ | 3.337 (0.427, 9.074) | 0.299 (0.011, 2.137)§ | 2.167 (0.241, 8.188) | 0.299 (0.127, 2.501)|| |
Pancreatic pseudocyst | 17 (9.4%) | 223 (15.3%)# | 41 (10.0%) | 199 (16.3%)|| | 89 (13.0%) | 151 (15.9%)# | 146 (14.0%) | 94 (16.0%)# | 186 (14.0%) | 54 (17.6%)# | 226 (14.8%) | 14 (13.2%)# |
Time between onset and pseudocyst formation* | 2.836 (0.656, 8.838) | 2.164 (0.290, 5.836)# | 5.068 (1.238, 8.922) | 1.608 (0.290, 5.249)|| | 4.737 (1.000, 8.496) | 1.025 (0.290, 3.975)§ | 3.874 (0.331, 7.258) | 1.000 (0.173, 3.605)|| | 3.501 (0.414, 7.258) | 1.000 (0.052, 2.422)§ | 2.389 (0.329, 6.334) | 1.000 (0.000, 2.558)|| |
Death | 0 (0.0%) | 57 (3.9%)|| | 4 (1.0%) | 53 (4.3%)§ | 4 (0.6%) | 53 (5.6%)§ | 12 (1.1%) | 45 (7.7%)§ | 25 (1.9%) | 32 (10.5%)§ | 38 (2.5%) | 19 (17.9%)§ |
Pancreatic cancer | 0 (0.0%) | 18 (1.2%)# | 2 (0.5%) | 16 (1.3%)# | 2 (0.3%) | 16 (1.7%)|| | 7 (0.7%) | 11 (1.9%)¶ | 14 (1.1%) | 4 (1.3%)# | 18 (1.2%) | 0 (0.0%)# |
Morphology of MPD‡ | § | § | § | § | § | § | ||||||
Pancreatic stone alone | 67 (37.2%) | 388 (26.7%) | 137 (33.3%) | 318 (26.0%) | 217 (31.7%) | 238 (25.1%) | 303 (29.0%) | 152 (25.9%) | 379 (28.6%) | 76 (24.8%) | 433 (28.4%) | 22 (20.8%) |
MPD stenosis alone | 38 (21.1%) | 459 (31.6%) | 79 (19.2%) | 418 (34.2%) | 144 (21.0%) | 353 (37.2%) | 253 (24.2%) | 244 (41.5%) | 355 (26.8%) | 142 (46.4%) | 442 (28.9%) | 55 (51.9%) |
MPD stenosis and stone | 68 (37.8%) | 451 (31.0%) | 177 (43.0%) | 342 (28.0%) | 279 (40.7%) | 240 (25.3%) | 403 (38.6%) | 116 (19.7%) | 470 (35.4%) | 49 (16.0%) | 500 (32.7%) | 19 (17.9%) |
Complex pathologic changes | 7 (3.9%) | 155 (10.7%) | 19 (4.6%) | 143 (11.7%) | 45 (6.6%) | 117 (12.3%) | 86 (8.2%) | 76 (12.9%) | 123 (9.3%) | 39 (12.7) | 152 (10.0%) | 10 (9.4%) |
Type of pain | § | § | § | § | § | ¶ | ||||||
Recurrent acute pancreatitis | 50 (27.8%) | 437 (29.8%) | 138 (33.5%) | 349 (28.6%) | 223 (32.6%) | 264 (27.8%) | 318 (30.4%) | 169 (28.7%) | 403 (30.4%) | 84 (27.5%) | 449 (29.4%) | 38 (35.8%) |
Recurrent pain | 43 (23.9%) | 471 (32.4%) | 102 (24.8%) | 412 (33.7%) | 174 (25.4%) | 340 (35.9%) | 292 (27.9%) | 222 (37.8%) | 392 (29.5%) | 122 (39.9%) | 472 (30.9%) | 42 (39.6%) |
Recurrent acute pancreatitis and pain | 75 (41.7%) | 344 (23.7%) | 144 (35.0%) | 275 (22.5%) | 223 (32.6%) | 196 (20.7%) | 317 (30.3%) | 102 (17.3%) | 381 (28.7%) | 38 (12.4%) | 406 (26.6%) | 13 (12.3%) |
Chronic pain | 11 (6.1%) | 68 (4.7%) | 19 (4.6%) | 60 (4.9%) | 33 (4.8%) | 46 (4.9%) | 50 (4.8%) | 29 (4.9%) | 381 (28.7%) | 38 (12.4%) | 73 (4.8%) | 6 (5.7%) |
Without pain | 1 (0.6%) | 133 (9.2%) | 9 (2.2%) | 125 (10.2%) | 32 (4.7%) | 102 (10.8%) | 68 (6.5%) | 66 (11.2%) | 85 (6.4%) | 49 (16.0%) | 127 (8.3%) | 7 (6.6%) |